Charles Weidman serves as the Co-Founder, Chief Product Officer (CPO), and Chief Operating Officer (COO) at TYDEi Health, where he leverages his extensive expertise in healthcare technology to drive innovation and operational excellence. With a strong foundation in healthcare sales and operations, Charles has been...
Charles Weidman serves as the Co-Founder, Chief Product Officer (CPO), and Chief Operating Officer (COO) at TYDEi Health, where he leverages his extensive expertise in healthcare technology to drive innovation and operational excellence. With a strong foundation in healthcare sales and operations, Charles has been instrumental in the development of a cutting-edge Enterprise Procure-to-Pay (P2P) software system tailored specifically for the healthcare sector. This commercial-level solution not only streamlines procurement processes but also integrates smart contract-based logic for vendor contract management, enhancing efficiency in supply chain operations, accounts payable, receivables, and payments.
In his current role, Charles is leading key projects that focus on creating enterprise dashboards designed for case costing, inventory velocity, and vendor spend analysis. These dashboards empower healthcare organizations to make data-driven decisions, optimizing resource allocation and improving overall financial performance. Additionally, his work in developing AI modeling tools is paving the way for predictive analytics in inventory management, enabling healthcare providers to anticipate needs and reduce waste.
Charles’s diverse skill set encompasses areas such as orthopedic sales, territory development, and robotics, making him a multifaceted leader in the healthcare technology landscape. His commitment to continuous improvement and innovation is reflected in his approach to training and research, ensuring that TYDEi Health remains at the forefront of industry advancements. With a mission that aligns with his personal values, Charles is dedicated to enhancing the quality of care through technology, all unto the LORD.
